Pictet Asset Management (UK)’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FAM
Pictet Asset Management (UK)'s NEO Position: Q2 2021 in Review
Pictet Asset Management (UK) reduced its NeoGenomics (NEO) stake by 5.9% in Q2 2021, selling an estimated $21.2K and leaving 7,615 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.
Pictet Asset Management (UK) first reported a position in NEO in Q3 2020 and has held it in 4 quarters since. The position peaked at $473K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.
- Pictet Asset Management (UK) held 7,615 shares of NeoGenomics worth $344K as of Q2 2021.
- Pictet Asset Management (UK) sold 478 NeoGenomics shares in Q2 2021, an estimated $21.2K.
- NeoGenomics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1354 holding.
- Pictet Asset Management (UK) first reported a position in NeoGenomics in Q3 2020 and has held it in 4 quarters since.
- Pictet Asset Management (UK)'s NeoGenomics position peaked at $473K in Q4 2020.
- 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.